Gland Pharma Limited has informed the Exchange regarding Change in Director(s) of the company.
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma's shareholders approved the reappointment of Mr. Essaji Goolam Vahanvati as an Independent Director for a second term of five years, effective September 30, 2025, at the 47th Annual General Meeting on August 28, 2025. He will also receive commission on profits as remuneration, approved via a special resolution. Mr. Vahanvati, a law graduate practicing in the Supreme Court of India and Delhi High Court, has served on the board since September 30, 2020. He is not debarred from holding a directorship by any regulatory authority.
This is a routine governance update with no material impact on the stock; it reflects continuity on the board rather than any leadership or strategic change.